| Literature DB >> 2439189 |
N Tanigawa, T Shimomatsuya, K Takahashi, Y Inomata, K Tanaka, K Satomura, Y Hikasa, M Hashida, S Muranishi, H Sezaki.
Abstract
Of the several types of treatment for cystic hygromas and lymphangiomas, surgical excision has been the preferred treatment. However, there is a high recurrence rate because lymphangiomas tend to infiltrate the surrounding tissues. Bleomycin in a microsphere-in-oil (S/O) emulsion was used in this study as a sclerosing agent for lymphangiomas. Experimental studies using domestic rabbits showed that the bleomycin emulsion caused more marked fibrotic changes at the injection site than other formulations, such as a blank emulsion and bleomycin solution. In clinical trials, 27 of 33 patients received bleomycin S/O emulsion injected directly into the tumors with satisfactory results. Histologic pictures of the clinically resected specimens confirmed the findings of the experimental studies. Comparative studies of treatments between bleomycin S/O emulsion and surgery indicated that injection therapy of bleomycin S/O emulsion would be more beneficial than surgical excisions.Entities:
Mesh:
Substances:
Year: 1987 PMID: 2439189 DOI: 10.1002/1097-0142(19870815)60:4<741::aid-cncr2820600406>3.0.co;2-2
Source DB: PubMed Journal: Cancer ISSN: 0008-543X Impact factor: 6.860